Papel dos leucócitos na fisiopatologia da anemia falciforme / Role of leukocytes in sickle cell anemia pathophysiology
Camila Bononi de Almeida
DATA DE PUBLICAÇÃO
Sickle Cell Disease (SCD) is a disorder of hemoglobin synthesis, caused by a point mutation, and resulting in the production of abnormal sickle hemoglobin, HbS. The consequence of low oxygen levels is HbS polymerization, which is responsible for the vaso-occlusive phenomenon that is the hallmark of the disease. SCD is a chronic inflammatory disease characterized by alterations in cytokine levels and an increase in leukocytes number and endothelial cell injury. Leukocytes play an important role in SCD since their recruitment to the microvasculature, consequent adhesion to the vessel wall, and interactions with other cells may interrupt the blood flow and culminate in vaso-occlusion. Therapeutic strategies for SCD treatment are based on three points: 1) reduction of intracellular HbS concentration, for example, by increasing the erythrocytic HbF concentration; 2) reduction of inflammatory processes and oxidative stress; 3) inhibition of cellular adhesion and, as a consequence, a reduction in vaso-occlusion. HU is a chemotherapeutic drug used for SCD treatment. This drug is able to increase HbF concentrations and reduce white blood cells counts, although it has some adverse effects and some patients do not respond to this therapy. Thus, it is necessary to fully understand the mechanisms that contribute to the vaso-occlusive process, including the role of the leukocytes in this phenomenon. The goals of this study are: 1) To check the influence of factors present in SCD serum on mechanisms that may affect the neutrophil count and oxidative stress generation; 2) understand the role of neutrophils in the initiation and propagation of vascular inflammation and vaso-occlusion. Date indicate that factors present in the SCD serum are able to alter neutrophil apoptosis and induce reactive oxygen species (ROS) generation, possibly by the activation of the NADPH enzyme expressed in these cells. Additionally, results obtained from a SCD inflammatory mouse model indicate that an activation of the cGMP - dependent pathway can inhibit neutrophil adhesion to the vascular endothelium cells after inflammatory induction and that drugs that amplify the effects of HU may represent a potential new therapy for SCD treatment.
ACESSO AO ARTIGOhttp://libdigi.unicamp.br/document/?code=000811171
- Leucocitos e inflamação em pacientes com anemia falciforme
- Avaliação funcional dos eosinófilos na anemia falciforme e o efeito do tratamento com hidroxiureia
- Papel do fator de necrose tumoral (TNF-a) na fisiopatologia da disfunção erétil.
- Role of inflammatory mediators in the adhesive properties of neutrophils from sickle cell disease individuals and the effects of cyclic nucleotide drug modulators on this adhesion
- Role of nitric oxide and the cyclic guanosine monophosphate dependent patway on the adhesive properties leucocytes of sickle cell disease patients